Navin Fluorine Q3 Results: Navin Fluorine International announced its results for the quarter ending December 2025 (Q3FY26) on February 2. The company posted a strong set of financial numbers, posting ...

WASHINGTON, DC – The Center for Strategic and International Studies (CSIS), a bipartisan, nonprofit policy research organization dedicated to advancing practical ideas to address the world’s greatest ...

Dr. Reddy’s Laboratories is preparing for what could become one of its most significant launches in years, oral semaglutide, the much‑watched GLP‑1 pill used for diabetes and weight management. “We ...

HYDERABAD, Feb ‌17 (Reuters) - Indian drugmaker ‌Dr Reddy's laboratories aims to launch a generic version of Novo Nordisk's blockbuster weight loss ‌drug Wegovy, ⁠subject to approval, at a price ...

The Supreme Court on Tuesday dismissed appeals in the 2002 death case of actress Prathyusha, ruling out murder and affirming Gudipalli Siddhartha Reddy’s conviction for abetment of suicide. Reddy ...

HYDERABAD, Feb 17 (Reuters) - Indian drugmaker Dr Reddy’s Laboratories (REDY.NS), opens new tab hopes to launch a generic version of Novo Nordisk’s (NOVOb.CO), opens new tab blockbuster weight‑loss ...

Declaring “nil” tax dues in the assets and liabilities statement filed with his nomination papers - despite owing ₹1.3 crore in property tax arrears since 2018 - cost S.N. Subba Reddy his MLA post.

Shares of Navin Fluorine International Ltd will be in focus heading into trade on Tuesday, February 10, after the company reported a robust set of figures for the December quarter of the financial ...

Feb 18 (Reuters) - India's Stable Money has raised $25 million in a round led by Peak XV Partners, as the fixed-income investment platform aims to triple its assets under management by year-end to 150 ...

Citi maintained a sell rating and raised its target price to Rs 5,550 from Rs 4,900. It noted that EBITDA rose 110 per cent year-on-year and margins improved sharply, but said the stock’s recent rally ...